About Good Start Genetics
Good Start Genetics is a company based in Boston (United States) founded in 2008 was acquired by Molecular Loop in October 2018. Good Start Genetics has raised $32.16 million across 3 funding rounds from investors including Invitae, Orbimed and Molecular Loop. Good Start Genetics operates in a competitive market with competitors including Everlywell, Viome, Color, Invitae and Counsyl, among others.
- Headquarter Boston, United States
- SectorsHealthcare
- Website goodstartgenetics.com
- Social LinkedIn X Facebook
- Acquired by Molecular Loop (Oct 2018)
- Total Equity Funding$32.16M (USD)
in 3 rounds
- Latest Funding Round$28M (USD), Debt – Venture
May 2013
- InvestorsInvitae
& 5 more
- Acquired by
Funding Insights of Good Start Genetics
Good Start Genetics has successfully raised a total of $32.16M across 3 strategic funding rounds. The most recent funding activity was a Debt – Venture round of $28 million completed in May 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $32.16M
- Total Rounds 3
- Last Round Debt – Venture — $28M
- First Round $18.16M
(Sep 2010)
- Investors Count 4
All 3 funding rounds of Good Start Genetics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2013 | $28M | Debt – Venture | – | – | |
| Apr 2012 | $14M | Series B | – | Orbimed, Safeguard Scientifics | – |
| Sep 2010 | $18.16M | Series A | – | Orbimed, Safeguard Scientifics | – |
6 investors in total: 6 institutional.
Investors in Good Start Genetics
Good Start Genetics has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Invitae, Orbimed and Molecular Loop.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields. | 1989 | orbimed.com | New York, United States | |
Venture capital firm investing in early and growth stage companies | 1953 | safeguard.com | Radnor, United States | |
Venture capital fund focused on early-stage healthcare startups | – | svhealthinvestors.com | Boston, United States | |
CRG is recognized as a premier healthcare investment partner. | – | crglp.com | Houston, United States | |
Targeted DNA sequencing technology is developed for clinical use. | 2018 | molecularloop.com | Boston, United States | |
Home-based genetic tests for detecting diseases are provided to individuals. | 2010 | invitae.com | San Francisco, United States |
Investor details for Good Start Genetics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Good Start Genetics
5 dated milestones of Good Start Genetics across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Good Start Genetics is founded.
- Funding First funding round of $18.2M.
- Funding Latest funding round, Debt – Venture, of $28.0M.
- Exit Acquired by Invitae.
- Exit Acquired by Molecular Loop.
Competitors of Good Start Genetics
Good Start Genetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Everlywell, Viome, Color, Invitae and Counsyl, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| everlywell.com | 2014 | Austin, United States | $330M | 614 | At-home health tests for biomarkers, nutrition, and hormone analysis. | |
| viome.com | 2016 | Los Alamos, United States | $301.57M | 136 | Machine learning-based bioinformatics solutions for health insights are provided. | |
| color.com | 2013 | Burlingame, United States | $506.44M | 687 | Cancer care is delivered through a virtual clinic by Color. | |
| invitae.com | 2010 | San Francisco, United States | $189.56M | 1,700 | Home-based genetic tests for detecting diseases are provided to individuals. | |
| counsyl.com | 2007 | San Francisco, United States | $112.89M | 503 | DNA mapping for pre-pregnancy genetic testing, DNA and cancer screening | |
| variantbio.com | 2018 | Brooklyn, United States | $127.74M | – | Personalized therapeutics are developed using genomic data for rare diseases. | |
| geneplanet.com | 2008 | Ljubljana, Slovenia | $34.02M | – | DNA-based personalized health and fitness recommendations are offered. | |
| newtopia.com | 2008 | New York, United States | $13.1M | – | Health management platform is provided for employers and insurers. | |
| auxogyn.com | 2008 | Menlo Park, United States | $78.35M | 384 | Diagnostic technologies for IVF embryo viability assessment are developed. | |
| overture.life | 2017 | Palo Alto, United States | $49.2M | – | Embryology diagnosis devices are developed for medical professionals. |
Detailed competitors of Good Start Genetics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Good Start Genetics
Websites that share an audience with Good Start Genetics (goodstartgenetics.com).
Websites whose visitors overlap most with Good Start Genetics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
rmact.com | rmact.com | 100% | – | – | – |
clingensoc.org | clingensoc.org | 81% | – | #7,675,611 | – |
| kailosgenetics.com | 80% | 2.3K | #6,334,797 | View details | |
atlasgenetics.com | atlasgenetics.com | 80% | – | – | – |
| sophiagenetics.com | 80% | 39.4K | #679,201 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for Good Start Genetics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Good Start Genetics
Complete news archive for Good Start Genetics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Good Start Genetics
10 companies that operate in the same segment as Good Start Genetics (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Good Start Genetics
Good Start Genetics was founded in 2008 and raised its 1st funding round 2 years after it was founded.
Good Start Genetics is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Good Start Genetics is a funded company, having raised a total of $32.16M across 3 funding rounds to date. The company's 1st funding round was a Series A of $18.16M, raised on Sep 2010.
Good Start Genetics is a molecular genetic information company offering carrier screening for inherited genetic diseases. The company provides genetic carrier screening tests for known and novel mutations that cause inherited genetic disorders. The company is using next generation sequencing (NGS) and other proven genetic screening technologies for their genetic tests.Good Start Genetics provides carrier screening for all disorders recommended by the American Congress of Obstetricians and Gynecologists the American College of Medical Genetics. It has two products: GeneVu for carrier testing and EmbryVu for embryo screening. Customers can order GeneVu through Amazon as well.
Good Start Genetics's top competitors include Viome, Variant Bio and Newtopia.
Good Start Genetics has 6 investors. Key investors include Invitae, Orbimed, Molecular Loop, Safeguard Scientifics, and SV Health Investors.
Yes. Good Start Genetics was acquired by Molecular Loop in October 2018.